Paracetamol Use in Patients With Osteoarthritis and Lower Back Pain: Infodemiology Study and Observational Analysis of Electronic Medical Record Data
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Lower back pain (LBP) and osteoarthritis (OA) are common musculoskeletal disorders and account for around 17.0% of years lived with disability worldwide; however, there is a lack of real-world data on these conditions. Paracetamol brands are frequently prescribed in France for musculoskeletal pain and include Doliprane, Dafalgan, and Ixprim (tramadol-paracetamol). Objective: The objective of this retrospective study was to understand the journey of patients with LBP or OA when treated with paracetamol. Methods: Three studies were undertaken. Two studies analyzed electronic medical records from general practitioners (GPs) and rheumatologists of patients with OA or LBP, who had received at least one paracetamol prescription between 2013 and 2018 in France. Data were extracted, anonymized, and stratified by gender, age, and provider specialty. The third study, an infodemiology study, analyzed associations between terms used on public medical forums and Twitter in France and the United States for OA only. Results: In the first 2 studies, among patients with LBP (98,998), most (n=92,068, 93.0%) saw a GP, and Doliprane was a first-line therapy for 87.0% (n=86,128) of patients (71.0% [n=61,151] in combination with nonsteroidal anti-inflammatory drugs [NSAIDs] or opioids). Among patients with OA (99,997), most (n=84,997, 85.0%) saw a GP, and Doliprane was a first-line therapy for 83.0% (n=82,998) of patients (62.0% [n=51,459] in combination). Overall, paracetamol monotherapy prescriptions decreased as episodes increased. In the third study, in line with available literature, the data confirmed that the prevalence of OA increases with age (91.5% [212,875/232,650] above 41 years), OA is more predominant in females (46,530/232,650, 20.0%), and paracetamol use varies between GPs and rheumatologists. Conclusions: This health surveillance analysis provides a better understanding of the journey for patients with LBP or OA. These data confirmed that although paracetamol remains the most common first-line analgesic for patients with LBP and OA, usage varies among patients and health care specialists, and there are concerns over efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Paracetamol continues to occupy a privileged position within healthcare systems despite growing uncertainty regarding its efficacy in many chronic pain conditions [ 2 , 9 , 18 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“making paracetamol a paradigmatic example of the evidence-practice gap rather than an isolated case [ 18 , 57 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of major musculoskeletal conditions.
(2003) · Europe PMC (PubMed Central) · Cited by 3,521
Qaseem, A., Wilt, T. J., McLean, R. M., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2367 · Cited by 3,234
OARSI guidelines for the non-surgical management of knee osteoarthritis
McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. M., Hawker, G. A., Henrotin, Y., Hunter, D. J., Kawaguchi, H., et al. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.01.003 · Cited by 3,110 · cited 1×
“Multiple guidelines, including the 2016 recommendations from the National Institute of Clinical Excellence (NICE) and the 2017 American College of Physicians clinical guidelines, advise against the use of paracetamol alone as a first-line therapy for acute LBP [17,55,63-65]; however, paracetamol is still recommended a…”
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41142 · Cited by 1,965
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Cui, A., Li, H., Wang, D., Zhong, J., Chen, Y., & Lu, H. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100587 · Cited by 1,614 · cited 1×
“Symptomatic knee OA is one of the more common forms of OA, experienced by approximately 22.9% of individuals over 40 years, and is a significant cause of disability [25,26].”
InfluentialBlagojevic, M., Jinks, C., Jeffery, A., & Jordan, K. P. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.08.010 · Cited by 1,397 · cited 1×
“owing to the degenerative nature of this disease that progresses with age [46,47].”
Research works printed but not linked: 10
- Woolf, AD, 2003, Bull World Health Organ, 81, 646
- Robertson, D, 2017, J Can Chiropr Assoc, 61, 96
- Patel, AT, 2000, Am Fam Physician, 61, 1779
- Dhillon, KS, 2016, Malays Orthop J, 10, 61
- 2016, Low Back Pain and Sciatica in Over 16s: Assessment and Management
- Ordeberg, G, 2004, Osteoarthritic Joint Pain: Novartis Foundation Symposium 260, Volume 260
- 2014, Care and Management in Adults
- Chevreul, K, 2015, Health Syst Transit, 17, 1
- Negrini, S, 2006, Eura Medicophys, 42, 151
- 10.7326/m16-2367 · DOI · Paper page
Cited by
DNA Supramolecular Hydrogel-Enabled Sustained Delivery of Metformin for Relieving Osteoarthritis
Zhang, C., Huang, H., Chen, J., Zuo, T., Ou, Q., Ruan, G., He, J., & Ding, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20496 · Cited by 40
Cao, Z., Han, K., Lu, H., Illangamudalige, S., Shaheed, C. A., Chen, L., McLachlan, A. J., Patanwala, A. E., Maher, C. G., Lin, C. C., et al. (2024) · Drugs · doi:10.1007/s40265-024-02065-w · Cited by 38
The Challenges of Pain Assessment in Geriatric Patients With Dementia: A Review
El-Tallawy, S. N., Ahmed, R. S., Shabi, S. M., Al-Zabidi, F. Z., Zaidi, A. R. Z., Varrassi, G., Pergolizzi, J. V., LeQuang, J. A., & Paladini, A. (2023) · Cureus · doi:10.7759/cureus.49639 · Cited by 31
“The nonsteroidal anti-inflammatory drugs (NSAIDs) are not recommended in this age group because of the associated side effects on the cardiovascular system, renal impairment, and the increased risk of gastrointestinal bleeding [22].”
BackgroundNeuropharmacology of Neuropathic Pain: A Systematic Review
Mian, M. U., Afzal, M., Butt, A. A., Ijaz, M., Khalil, K., Abbasi, M., Fatima, M., Asif, M. F., Nadeem, S., Jha, S., et al. (2024) · Cureus · doi:10.7759/cureus.69028 · Cited by 25
“Paracetamol is the first-line therapy for patients with OA [59].”
BackgroundChen, S., Xu, H., He, Y., Meng, C., Fan, Y., Qu, Y., Wang, Y.-G., Zhou, W., Huang, X., & You, H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110781 · Cited by 12
Coates, G., Clewes, P., Lohan, C., Stevenson, H., Wood, R. P., Tritton, T., Knaggs, R., Dickson, A. J., & Walsh, D. A. (2023) · International Journal of Clinical Practice · doi:10.1155/2023/5105810 · Cited by 9
“Pharmacological management includes paracetamol and nonsteroidal anti-infammatory drugs, and opioids have also been used, despite a lack of evidence of their efcacy [15, 16].”
BackgroundCipolloni, V., Bonifacio, M., Musorrofiti, M. G., Saggini, R., Caldarola, A., Grossi, G., Piazza, R., Mangrella, M., Trastulli, D., & Conforti, A. (2026) · Life · doi:10.3390/life16060962 · Cited by 7
“In routine OA care, where treatment pathways frequently involve switching, combination therapy, and discontinuation over time, longer follow-up may be especially informative [1].”
InfluentialParacetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management
Nicolas, J., Leoni, M. L. G., Van Tran, Y., Van Phong, P., Farì, G., Puttini, P. S., Kaye, A. D., & Varrassi, G. (2026) · Current Pain and Headache Reports · doi:10.1007/s11916-026-01553-w
Cittée, J., Lemire, P., Annenkova, A., Milon, J., & Perrot, S. (2023) · Douleur et Analgésie · doi:10.3166/dea-2022-0268
Knowledge of primary care physicians about management of patients with knee osteoarthritis
Jimenez, C. O. B. (2025) · Universidad Peruana Cayetano Heredia Institutional Repository
Metadata
- Authors
- Pickering, G., Mezouar, L., Kechemir, H., & Ebel-Bitoun, C.
- Affiliations
- Sanofi (France) (FR)
- Venue
- JMIR Public Health and Surveillance
- Publisher
- JMIR Publications Inc.
- Published
- 2022-10-27
- Volume
- 8
- Issue
- 10
- Pages
- e37790
- ISSN
- 2369-2960 (ISSN-L)
- PMC
- PMC9650576
- OpenAlex
- W4307444501
- Cited by
- 9
- References
- 61
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 5
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Public Health and Surveillance (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- paracetamol, osteoarthritis, low back pain, musculoskeletal pain, prescribing patterns, first-line therapy, nonsteroidal anti-inflammatory drugs, general practitioners, rheumatologists, infodemiology, Twitter, online health communities, real-world data, France, United States
- MeSH terms
- Acetaminophen, Infodemiology, Adult, Female, Humans, Male, Osteoarthritis, Retrospective Studies, Low Back Pain, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.